Marshall Wace North America’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Marshall Wace North America’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$510K	Buy	+2,478	New	+$487K	﹤0.01%	1113
2020 Q4	–	Sell	-38,171	Closed	-$2.89M	–	1653
2020 Q3	$2.89M	Buy	+38,171	New	+$2.16M	0.02%	491

Other funds holding SWAV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Marshall Wace North America's SWAV Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2021: 2,478 shares worth $510K. The stake represents ﹤0.01% of the portfolio and ranks #1113 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in SWAV as recently as Q3 2020.

Marshall Wace North America first reported a position in SWAV in Q3 2020 and has held it in 2 quarters since. The position peaked at $2.89M in Q3 2020. 266 funds tracked by Wall St. Rank hold SWAV as of Q3 2021.

Marshall Wace North America held 2,478 shares of Shockwave Medical, Inc. Common Stock worth $510K as of Q3 2021.
Shockwave Medical, Inc. Common Stock was a new Marshall Wace North America position in Q3 2021.
Shockwave Medical, Inc. Common Stock made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1113 holding.
Marshall Wace North America first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and has held it in 2 quarters since.
Marshall Wace North America's Shockwave Medical, Inc. Common Stock position peaked at $2.89M in Q3 2020.
266 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.